21 November 2025
Cancers | Feature Papers from the First Half of 2025 in the “Tumor Microenvironment” Section
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Tumor Microenvironment”, which are listed below:
1. “Bridging Immune Evasion and Vascular Dynamics for Novel Therapeutic Frontiers in Hepatocellular Carcinoma”
by Sulin Wu, Namrata Anand, Zhoubo Guo, Mingyang Li, Marcos Santiago Figueroa, Lauren Jung, Sarah Kelly and Joseph W. Franses
Cancers 2025, 17(11), 1860; https://doi.org/10.3390/cancers17111860
Available online: https://www.mdpi.com/2072-6694/17/11/1860
2. “Dynamic Multilevel Regulation of EGFR, KRAS, and MYC Oncogenes: Driving Cancer Cell Proliferation Through (Epi)Genetic and Post-Transcriptional/Translational Pathways”
by Mario Seres, Katarina Spacayova, Zdena Sulova, Jana Spaldova, Albert Breier and Lucia Pavlikova
Cancers 2025, 17(2), 248; https://doi.org/10.3390/cancers17020248
Available online: https://www.mdpi.com/2072-6694/17/2/248
3. “A Review of Telomere Attrition in Cancer and Aging: Current Molecular Insights and Future Therapeutic Approaches”
by Mina Iskandar, Miguel Xiao Barbero, Muhamed Jaber, Roy Chen, Romulo Gomez-Guevara, Edwin Cruz and Sandy Westerheide
Cancers 2025, 17(2), 257; https://doi.org/10.3390/cancers17020257
Available online: https://www.mdpi.com/2072-6694/17/2/257
4. “The Complexity of Malignant Glioma Treatment”
by Linde F. C. Kampers, Dennis S. Metselaar, Maria Vinci, Fabio Scirocchi, Sophie Veldhuijzen van Zanten, Matthias Eyrich, Veronica Biassoni, Esther Hulleman, Michael Karremann, Wilfried Stücker et al.
Cancers 2025, 17(5), 879; https://doi.org/10.3390/cancers17050879
Available online: https://www.mdpi.com/2072-6694/17/5/879
5. “Optimizing Cancer Treatment Through Gut Microbiome Modulation”
by Kyuri Kim, Mingyu Lee, Yoojin Shin, Yoonji Lee and Tae-Jung Kim
Cancers 2025, 17(7), 1252; https://doi.org/10.3390/cancers17071252
Available online: https://www.mdpi.com/2072-6694/17/7/1252
6. “Metabolic Signaling in the Tumor Microenvironment”
by Ryan Clay, Kunyang Li and Lingtao Jin
Cancers 2025, 17(1), 155; https://doi.org/10.3390/cancers17010155
Available online: https://www.mdpi.com/2072-6694/17/1/155
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office